MURRAY HILL, N.J.--(BUSINESS WIRE)--Jan. 18, 2006--C. R. Bard,
Inc. (NYSE-BCR) today announced that it has acquired certain assets
from PST, LLC, of Gainesville, Florida, related to new self-expanding
nitinol stent technology. Terms of the transaction were not disclosed.
Self-expanding stents are used to maintain patency within
anatomical lumens, such as those associated with peripheral vascular,
urological, biliary and tracheal-bronchial applications. The
technology acquired includes a development stage stent specifically
designed to have the flexibility to meet the demands of tortuous and
Timothy M. Ring, chairman and chief executive officer, commented,
"The PST device currently in development represents an excellent
strategic fit and enhancement to Bard's stent portfolio. The related
technology and intellectual property also provide a platform for the
development of further generations of products. We expect this
acquisition to play an important role in the future of our
self-expanding stent franchise."
As part of the transaction, the company will record an acquisition
related research and development charge of approximately $6 million in
the first quarter of 2006.
C. R. Bard, Inc. (www.crbard.com), headquartered in Murray Hill,
N.J., is a leading multinational developer, manufacturer, and marketer
of innovative, life-enhancing medical technologies in the fields of
vascular, urology, oncology and surgical specialty products.
This press release may contain forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995,
which are based on management's current expectations, the accuracy of
which is necessarily subject to risks and uncertainties. These
statements are not historical in nature and use words such as
"anticipate", "estimate", "expect", "project", "intend", "forecast",
"plan", "believe", and other words of similar meaning in connection
with any discussion of future operating or financial performance. Many
factors may cause actual results to differ materially from anticipated
results including product developments, sales efforts, income tax
matters, the outcomes of contingencies such as legal proceedings, and
other economic, business, competitive and regulatory factors. The
company undertakes no obligation to update its forward-looking
statements. Please refer to our September 30, 2005 10-Q for more
detailed information about these and other factors that may cause
actual results to differ materially from those expressed or implied.
CONTACT: C. R. Bard, Inc.
Eric J. Shick, 908-277-8413
Holly P. Glass, 703-754-2848
SOURCE: C. R. Bard, Inc.